Structural Biology and Molecular Modeling Techniques

Structural Biology and Molecular Modeling Techniques

Global Structural Biology and Molecular Modeling Techniques Market to Reach US$33.0 Billion by 2030

The global market for Structural Biology and Molecular Modeling Techniques estimated at US$11.2 Billion in the year 2023, is expected to reach US$33.0 Billion by 2030, growing at a CAGR of 16.7% over the analysis period 2023-2030. SaaS & Standalone Modeling Tool, one of the segments analyzed in the report, is expected to record a 17.8% CAGR and reach US$20.2 Billion by the end of the analysis period. Growth in the Databases Tool segment is estimated at 14.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.9 Billion While China is Forecast to Grow at 21.6% CAGR

The Structural Biology and Molecular Modeling Techniques market in the U.S. is estimated at US$2.9 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$8.7 Billion by the year 2030 trailing a CAGR of 21.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 11.5% and 14.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.7% CAGR.

Global Structural Biology and Molecular Modeling Techniques Market - Key Trends and Drivers Summarized

How Are Structural Biology and Molecular Modeling Techniques Advancing Drug Discovery?

Structural biology and molecular modeling techniques involve studying the three-dimensional structures of biomolecules and simulating their interactions to understand biological processes at the molecular level. These techniques are crucial in drug discovery, protein engineering, and understanding disease mechanisms. By providing insights into the structures of proteins, DNA, and other biomolecules, these approaches allow researchers to identify drug targets, design new drugs, and predict their interactions with biological systems. As pharmaceutical companies aim to accelerate drug development and create targeted therapies, structural biology and molecular modeling have become indispensable tools in modern biotechnology and life sciences.

What Are the Key Segments in the Structural Biology and Molecular Modeling Market?

Key technologies include X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, cryo-electron microscopy (cryo-EM), and computational modeling, with X-ray crystallography holding the largest market share due to its ability to provide high-resolution structures of proteins and other biomolecules. Applications cover drug discovery, protein engineering, genomics, and disease research, with drug discovery representing a significant segment driven by the need for precise molecular insights to design effective drugs. End-users include pharmaceutical companies, research institutes, biotechnology firms, and academic institutions, with pharmaceutical companies leading the market as they invest heavily in structural biology to develop novel therapeutics.

How Are Structural Biology and Molecular Modeling Integrated Across Drug Development?

In drug discovery, structural biology techniques like X-ray crystallography and cryo-EM help visualize the structures of proteins and identify binding sites for potential drugs, enabling rational drug design and structure-based optimization. Computational modeling predicts the interactions between drugs and their targets, simulating the effects of different molecular modifications, which supports the design of more potent and selective drugs. In protein engineering, molecular modeling aids in modifying enzymes and proteins to enhance their stability, activity, or specificity, leading to new biopharmaceuticals and industrial enzymes. Additionally, genomics and disease research benefit from structural biology by identifying genetic mutations that alter protein structures, aiding in the development of personalized therapies.

What Factors Are Driving the Growth in the Structural Biology and Molecular Modeling Market?

The growth in the Structural Biology and Molecular Modeling market is driven by several factors, including increasing demand for targeted drug discovery and precision medicine that require detailed molecular insights. Advancements in imaging techniques like cryo-EM, faster computing power, and machine learning algorithms have improved the resolution, accuracy, and speed of structural analysis and modeling, supporting broader applications in drug development and disease research. The focus on developing treatments for complex diseases like cancer, neurodegenerative disorders, and infectious diseases has further fueled demand, as researchers seek to understand disease mechanisms and design effective therapies. Additionally, rising investments in biotechnology, expanded research collaborations, and government funding for life sciences research have contributed to market growth, encouraging the use of structural biology and molecular modeling in drug discovery and biomedical research.

SCOPE OF STUDY:

The report analyzes the Structural Biology and Molecular Modeling Techniques market in terms of US$ Million by the following Tool, and Geographic Regions/Countries:

Segments:
Tool (SaaS & Standalone Modeling, Databases, Visualization & Analysis, Other Tools)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 23 Featured) -

• Acellera Ltd.
• Affymetrix
• Agile Molecule
• Agilent Technologies, Inc.
• Bioinformatic LLC
• Biomax Informatics AG
• Bruker Daltonics Inc.
• Chemical Computing Group
• CLC bio
• Dassault Systemes
• Illumina

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.